Glauconix left darkbackground

Glauconix Biosciences

Glauconix is a contract research company utilizing a patented platform which cuts development costs for bringing effective vision saving drugs to market faster.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Albany, NY, US
  • Currency USD
  • Founded January 2015
  • Employees 6
  • Incorporation Type C-corp
  • Website glauconix-biosciences.com

Company Summary

Glauconix is contract research organization (CRO) serving the biopharma industry by providing an innovative service using a patented platform to accelerate glaucoma drug development. The team is comprised of key opinion leaders in the ophthalmic industry. This year-old company has generated over $600K in customer revenue. Glauconix is raising capital to grow the company and meet the demands of the world’s largest pharmaceutical companies.


  • Default avatar
    Barbara Wirostko M.D.

Previous Investors

  • Default avatar
    Richard Frederick